Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessMultiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial
-
Article
Open AccessE-DNA IM or ID delivery prime enhances antibody and T cell responses following recombinant gp120 env boost
-
Article
Open AccessAntibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family
-
Article
Open AccessVaccine-induced ADCC-mediating antibodies target unique and overlap** envelope epitopes